We are a producer and official distributor of medical devices for the treatment of pain in the spine and joints. The products manufactured by our company produce a permanent magnetic field with the use of the innovative technology of MULTIGRADENT Magnetic Systems MMSTherapyTM - developed at the Institute of Physical-medical Research, which is a research and development part of our company.
The Institute has been operating since 1995, and its Scientific Council consists of prominent specialists from leading scientific and clinical centers. The Institute is a leader among scientific institutions dealing with the application of physical medicine in home therapy. Over the last 20 years, it has developed unique therapeutic methods that have already benefited over 100,000 people. Information on the Institute's activities can be found at www.ibf.com.pl as well as on Wikipedia and the Nauka Polska portal.
The goal of Primax Medica Sp. z o. o. meets the needs and meets the expectations of clients by providing them with medical devices in accordance with their expectations and the requirements of the Directive for medical devices 93/42 / EEC Annex II and EN ISO 13485: 2016 and EN ISO 13485: 2016 / AC: 2016 - and all this in compliance with the law and based on high ethical standards. We strive to be the leader in the field of offered medical devices on the Polish market. We gain competitive advantage through the use of new technologies and professional and professional service for all customers. In order to achieve full customer satisfaction, we conduct continuous market observation, train the crew, modernize technical infrastructure and cooperate with renowned entities with global reach. We invest in new technologies, systematically improving the quality of our medical products.
The DirectMagnetic brand is a series of magnetic products made of high quality components that provide aesthetic and functional qualities and are:
EFFECTIVE AND SAFE
In our products we have used modern technology of MMS THERAPY multigradient magnetic systems, which guarantees their effectiveness and safety.
CONSTRUCTED BY SPECIALISTS
Our products are the result of the work of specialists from the Institute of Physical Research from Puszczykowo, who have over 20 years of experience in the field of solid magnetic field therapy.
MEDICAL COMPONENT
The products of the DIRECTMAGNETIC series are Class I medical devices for which we have performed a full clinical evaluation and safety analysis.
INDICATIONS
Musculoskeletal, rheumatic and post-traumatic pain.
We operate based on a sales distribution network, which we develop all the time, and also conduct direct sales based on the e-commerce channel. Our products can be successfully ordered directly on the company's website and in extensive sales points cooperating with our company.
ladies and gentlemen
We invite you to cooperate in the distribution of DirectMagnetic medical products, intended for the treatment of pain in the spine and joints. The products manufactured by our company produce a permanent magnetic field with the use of the innovative technology of MULTIGRADENT Magnetic Systems MMSTherapyTM - developed at the Institute of Physical-medical Research, which is a research and development part of our company.
The Institute has been operating since 1995, and its Scientific Council consists of prominent specialists from leading scientific and clinical centers. The Institute is a leader among scientific institutions dealing with the application of physical medicine in home therapy. Over the last 20 years, it has developed unique therapeutic methods that have already benefited over 100,000 people. Information on the activities can be found on the Institute's website at, and in, and on the portal.
We want to offer you a proven cooperation model based on B2B business channel with logistics support on the basis of dropshipping or cross-docking. The proposed model is a great solution that provides you with a trouble-free availability of our products, without the need to involve additional resources and create inventory. As part of the cooperation, we provide you with access to on-line warehouse resources, product photos and specialist descriptions of the products offered, company catalogs and a full range of product knowledge. For business entities with extensive sales infrastructure in the e-commerce model, we provide ready-made tools that integrate the offer.
Distribution of our products is not only an opportunity to expand your range, but also to provide your customers with high quality, effective and safe medical devices manufactured in Poland.
86.90.E - Other human health activities notelsewhere classified
22.29.Z - Manufacture of other plastic products
32.99.Z - Other manufacturing notelsewhere classified
46.46.Z - Wholesale of pharmaceutical goods
47.19.Z - Other retail sale in non-specialised stores
47.99.Z - Other retail sale not in stores, stalls or markets
62.01.Z - Computer programming activities
64.19.Z - Other monetary intermediation
64.99.Z - Other financial service activities, except insurance and pension funding not elsewhere classified
72.19.Z - Other research and experimental development on natural sciences and engineering
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0,8 | -0,4 | -0,5 | -27 |
EBITDA | -0,8 | -0,3 | -0,4 | -21,9 |
Short time liabilities | 0 | 1,2 | 1,2 | 0,4 |
Equity capital | 0,1 | -0,4 | -0,3 | 16,2 |
Operating profit (EBIT) | -0,8 | -0,4 | -0,4 | -21,3 |
Assets | 0,8 | 0,8 | 0,9 | 8,2 |
Net profit (loss) | -0,8 | -0,4 | -0,5 | -27 |
Cash | 0 | 0 | 0 | 58,4 |
Net income from sale | 0,4 | 0 | 0 | 710,8 |
Liabilities and provisions for liabilities | 0,8 | 1,2 | 1,2 | 0,7 |
Working assets | 0,1 | 0,1 | 0,1 | 15,1 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -1069,5 | 121,3 | 183,8 | 62,5 |
Equity capital to total assets | 9 | -44,2 | -34,3 | 9,9 |
Gross profit margin | -210,9 | -78 087 | -12 227,9 | 65 859,1 |
EBITDA Margin | -201,4 | -62 548,7 | -9408,5 | 53 140,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 0 | 766 227 | 94 851 | -671 376 |
Current financial liquidity indicator | 0.07473061978816986 | 0.08543774485588074 | 0 | |
Net dept to EBITDA | -0.8017511367797852 | -3.247236967086792 | -2.666820764541626 | 0,5 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane